Skip to content
Search

Latest Stories

Mental Health crisis grips England: 1 in 5 children grappling with probable mental disorders

Mental Health crisis grips England: 1 in 5 children grappling with probable mental disorders

An NHS survey exposes alarming rise in mental disorders among children and teens

A new report, published by the Office of National Statistics (ONS), has revealed worrying statistics about the mental health of children and young people in England.


The report is based on NHS survey on Mental Health of Children and Young People in England 2023, which showed that one in five children and young individuals aged eight to 25 were grappling with probable mental disorders.

The report highlighted that 20.3 per cent of eight to 16-year-olds showed signs of mental distress in 2023. Among 17 to 19-year-olds, the proportion rose to 23.3 per cent, while in 20 to 25-year-olds, it stood at 21.7 per cent.

The rates of probable mental disorders were similar for boys and girls, while for 17- to 25-year-olds, rates were twice as high for young women than young men.

Additionally, the report shed light on the prevalence of eating disorders. Shockingly, 12.5 per cent of 17 to 19-year-olds reported having an eating disorder in 2023, marking a significant increase from 0.8 per cent in 2017. Rates of eating disorders have soared among both young women and men in this age group over the years.

The findings also underscored children who were unlikely to have mental health disorders were more likely to have exercised, spent time in green spaces, or participated in activities in the week before the survey.

Dr Lade Smith CBE, president of the Royal College of Psychiatrists, urged the government and the NHS to prioritise children in their policy-making and funding decisions.

In response, a Department of Health and Social Care spokesman told The Telegraph, "Spending on mental health has increased by £4.7bn in cash terms since 2018/19 and we are increasing the coverage of mental health support teams in schools to reach at least 50pc of pupils in England by March 2025."

He added that 24 existing early support hubs across the country will receive additional funding to help provide support to those that need it, as announced in February.

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less